The identification of cholesterol as a possible risk factor for coronary heart disease was first made after it was recognized that in countries with a high mean blood cholesterol, the mortality from coronary heart disease was also high. Lowering cholesterol levels helps to reduce the chances of myocardial infarction and certain types of stroke. Andrew Tonkin and his team of internationally-recognized experts present the reader with sound clinical practices, based on scientific research and publications. Exploring the entire range of recent advances, Atherosclerosis and Heart Disease covers all aspects of atherosclerotic disease, including chronic manifestations, bypass surgery, stroke prevention and methods to lower blood pressure. Prof. Tonkin brings together a team of internationally-recognized experts to discuss sound clinical practices, based on scientific research and publications. They examine conventional and novel risk factors, acute coronary syndromes, and chronic manifestations of disease. The book provides a broad perspective on the disease process as it affects the patients doctors see every day and outlines current therapeutic strategies. It includes coverage of topics such as blood pressure and blood pressure-lowering therapy, lipid-modifying therapy, risk management strategies, and medical management of angina pectoris.